Drug or treatment

Sunvozertinib clinical trials

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• Sunvozertinib as follow-up treatment after surgery for early-stage NSCLC with EGFR exon 20 insertion or PACC mutations

  This trial tests whether taking sunvozertinib after complete surgery can lower the chance of cancer coming back in adults with stage IB–IIIA non-small cell lung cancer whose tumors have EGFR exon 20 insertion or PACC mutations.

  Recruiting at 4 sites Phase 3 Dizal Pharmaceuticals · Beijing and 48 other locations · NCT07182682

• Sunvozertinib for untreated advanced non-small cell lung cancer with uncommon EGFR mutations

  This will test whether the oral drug sunvozertinib can shrink tumors and be safe in adults with untreated advanced non‑small cell lung cancer who have uncommon EGFR mutations.

  Recruiting Phase 2 Fudan University · Shanghai · NCT07117890

• DZD6008 plus sunvozertinib for advanced EGFR‑mutant non‑small cell lung cancer

  This will test whether combining oral EGFR inhibitor DZD6008 with sunvozertinib is safe and helps shrink tumors in adults with advanced EGFR‑mutant non‑small cell lung cancer.

  Recruiting at 9 sites Phase 1/2 Dizal Pharmaceuticals · Beijing, Beijing Municipality and 13 other locations · NCT07079475

• Treatment of lung cancer with sunvozertinib

  This study is testing if a new drug called sunvozertinib can help people with stage II-IIIB non-small-cell lung cancer who have a specific genetic mutation feel better and improve their treatment outcomes.

  Recruiting Phase 2 Tang-Du Hospital · Changsha, Hunan and 2 other locations · NCT06864624

• Combination treatment for advanced lung cancer with specific mutations

  This study is testing a new combination of two drugs to see if it can help people with advanced lung cancer who have certain genetic mutations live longer without their cancer getting worse.

  Recruiting Phase 2 Hunan Province Tumor Hospital · Changsha, Hunan · NCT06355609

• Combination treatment for advanced lung cancer with specific mutations

  This study is testing a new combination of two drugs for people with advanced lung cancer who have specific genetic mutations to see if it helps them live longer without their cancer getting worse.

  Recruiting Phase 2 Hunan Province Tumor Hospital · Changsha, Hunan · NCT06348927

• Combining Sunvozertinib with chemotherapy for advanced lung cancer after TKI failure

  This study is testing if combining a new drug called Sunvozertinib with chemotherapy can help people with advanced lung cancer who didn't respond to previous treatments.

  Recruiting Phase 1/2 Sichuan University · Chengdu, Sichuan · NCT06195189

Quick answers

How many clinical trials of Sunvozertinib are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1/2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →